Samia S. Messeha

735 total citations
38 papers, 521 citations indexed

About

Samia S. Messeha is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Samia S. Messeha has authored 38 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Samia S. Messeha's work include Bioactive Compounds and Antitumor Agents (5 papers), Cancer-related Molecular Pathways (4 papers) and Nigella sativa pharmacological applications (4 papers). Samia S. Messeha is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Cancer-related Molecular Pathways (4 papers) and Nigella sativa pharmacological applications (4 papers). Samia S. Messeha collaborates with scholars based in United States and Libya. Samia S. Messeha's co-authors include Karam F. A. Soliman, Najla O. Zarmouh, Patricia Mendonca, Equar Taka, Getinet M. Adinew, Malak G. Kolta, Ramesh Badisa, Suresh Eyunni, Elizabeth Mazzio and Kinfe K. Redda and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Samia S. Messeha

37 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samia S. Messeha United States 16 246 95 86 76 62 38 521
Wafaa S. Ramadan United Arab Emirates 14 346 1.4× 103 1.1× 41 0.5× 53 0.7× 60 1.0× 39 627
Ching-Lung Liao Taiwan 13 284 1.2× 76 0.8× 42 0.5× 93 1.2× 98 1.6× 14 506
Najla O. Zarmouh United States 12 166 0.7× 51 0.5× 53 0.6× 44 0.6× 66 1.1× 20 372
Sangeetha Nagarajan India 17 333 1.4× 69 0.7× 55 0.6× 70 0.9× 100 1.6× 28 692
Yaoxian Wang China 11 240 1.0× 55 0.6× 35 0.4× 78 1.0× 42 0.7× 18 514
Ayako Tomizawa Japan 11 330 1.3× 68 0.7× 36 0.4× 65 0.9× 102 1.6× 19 620
Rıza Serttas Türkiye 8 208 0.8× 81 0.9× 29 0.3× 64 0.8× 78 1.3× 17 451
Guang‐Jian Du United States 12 441 1.8× 48 0.5× 66 0.8× 46 0.6× 69 1.1× 16 641
Equar Taka United States 17 246 1.0× 72 0.8× 203 2.4× 55 0.7× 61 1.0× 35 723
Sharon Varghese Qatar 6 405 1.6× 114 1.2× 63 0.7× 100 1.3× 103 1.7× 7 806

Countries citing papers authored by Samia S. Messeha

Since Specialization
Citations

This map shows the geographic impact of Samia S. Messeha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samia S. Messeha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samia S. Messeha more than expected).

Fields of papers citing papers by Samia S. Messeha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samia S. Messeha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samia S. Messeha. The network helps show where Samia S. Messeha may publish in the future.

Co-authorship network of co-authors of Samia S. Messeha

This figure shows the co-authorship network connecting the top 25 collaborators of Samia S. Messeha. A scholar is included among the top collaborators of Samia S. Messeha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samia S. Messeha. Samia S. Messeha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messeha, Samia S., et al.. (2025). Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis. Nutrients. 17(2). 267–267. 1 indexed citations
3.
Adinew, Getinet M., et al.. (2023). Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 24(12). 9878–9878. 5 indexed citations
4.
Messeha, Samia S., et al.. (2023). Involvement of AKT/PI3K Pathway in Sanguinarine’s Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells. Cancer Genomics & Proteomics. 20(4). 323–342. 10 indexed citations
5.
Mendonca, Patricia, et al.. (2023). Marine Carotenoid Fucoxanthin as a Promising Anticancer Therapeutic Against Triple-Negative Breast Cancer (TNBC). Journal of Pharmacology and Experimental Therapeutics. 385. 322–322. 1 indexed citations
7.
Adinew, Getinet M., et al.. (2023). The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer. Cancer Genomics & Proteomics. 20(3). 247–272. 6 indexed citations
8.
Messeha, Samia S., et al.. (2022). Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 23(15). 8329–8329. 18 indexed citations
9.
10.
Adinew, Getinet M., Samia S. Messeha, Ramesh Badisa, Equar Taka, & Karam F. A. Soliman. (2022). Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD‐L1 in MDA‐MB‐231 Triple‐Negative Breast Cancer Cells. The FASEB Journal. 36(S1). 9 indexed citations
13.
Messeha, Samia S., et al.. (2020). Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. European Journal of Pharmacology. 885. 173419–173419. 69 indexed citations
14.
Messeha, Samia S., et al.. (2020). Rosmarinic Acid‐Induced Apoptosis and Cell Cycle Arrest in Triple‐Negative Breast Cancer Cells. The FASEB Journal. 34(S1). 1–1. 4 indexed citations
15.
Messeha, Samia S., et al.. (2019). Effects of gossypol on apoptosis‑related gene expression in racially distinct triple‑negative breast cancer cells. Oncology Reports. 42(2). 467–478. 27 indexed citations
16.
Messeha, Samia S., et al.. (2018). The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells. PLoS ONE. 13(7). e0201116–e0201116. 27 indexed citations
17.
Messeha, Samia S., Najla O. Zarmouh, Patricia Mendonca, Malak G. Kolta, & Karam F. A. Soliman. (2017). The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells. Journal of Neuroimmunology. 313. 129–137. 24 indexed citations
18.
Zarmouh, Najla O., et al.. (2016). Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase‐A and ‐B Inhibitor. Evidence-based Complementary and Alternative Medicine. 2016(1). 1423052–1423052. 31 indexed citations
19.
Zarmouh, Najla O., et al.. (2016). Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors. European Journal of Medicinal Plants. 15(1). 1–16. 17 indexed citations
20.
Zarmouh, Najla O., et al.. (2015). Bavachinin and Genistein, Two Novel Human Monoamine Oxidase‐B (MAO‐B) Inhibitors in the Psoralea Corylifolia Seeds. The FASEB Journal. 29(S1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026